Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
Mahejibin Khan, Bijina J. Mathew, Priyal Gupta, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1292-1292
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 61
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 60
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Lorenza Romani, Federica Del Chierico, Gabriele Macari, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 49
Dissecting the role of the human microbiome in COVID-19 via metagenome-assembled genomes
Shanlin Ke, Scott T. Weiss, Yang‐Yu Liu
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
Pavlo Petakh, Valentyn Oksenych, Oleksandr Kamyshnyi
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114892-114892
Open Access | Times Cited: 27
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Intestinal barrier dysfunction as a key driver of severe COVID-19
Efthymios P. Tsounis, Christos Triantos, Christos Konstantakis, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 68-90
Open Access | Times Cited: 21
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection
Antonia Piazzesi, Stefania Pane, Federica Del Chierico, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens
Sterlin T. Raj, Alexander W. Bruce, Muralidharan Anbalagan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
Xiaomin Cheng, Yali Zhang, Yifan Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential
Gerasimos Eleftheriotis, Efthymios P. Tsounis, Ιωάννα Αγγελετοπούλου, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Cytokines and microRNAs in SARS-CoV-2: What do we know?
Fahimeh Zamani Rarani, Bahman Rashidi, Mohammad Hassan Jafari Najaf Abadi, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 219-242
Open Access | Times Cited: 24
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2802-2822
Open Access | Times Cited: 24
Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
Lei Xu, Chung S. Yang, Yanan Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
Nesa Kazemifard, Abolfazl Dehkohneh, Shaghayegh Baradaran Ghavami
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 4
The Important Role of Interleukin-2 in COVID-19
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 11
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19
Lucrezia Laterza, Lorenza Putignani, Carlo Romano Settanni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6623-6623
Open Access | Times Cited: 10
Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9
Dietary fiber (oligosaccharide and non-starch polysaccharide) in preventing and treating functional gastrointestinal disorders — Challenges and controversies: A review
Lingxiao Gong, Feiyue Liu, Jie Liu, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128835-128835
Closed Access | Times Cited: 9
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection
Santosh Shenoy
Inflammation Research (2021) Vol. 71, Iss. 1, pp. 13-26
Open Access | Times Cited: 22
The impact of infection with COVID-19 on the respiratory microbiome: A narrative review
Taiping Zhu, Jun Jin, Minhua Chen, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 1076-1087
Open Access | Times Cited: 14
Prophylactic effect of pectic oligosaccharides against poly I: C‐ induced virus‐like infection in BALB/c mice
Nidhi Sori, Saarika Pothuvan Kunnummal, Muthukumar Serva Peddha, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 14
A systematic review of gut microbiota profile in COVID‐19 patients and among those who have recovered from COVID‐19
Daniel Martin Simadibrata, Elvira Lesmana, Jeffri Gunawan, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 4, pp. 244-261
Closed Access | Times Cited: 8
Diet–gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders
Saarika Pothuvan Kunnummal, Mahejibin Khan
European Journal of Nutrition (2023) Vol. 63, Iss. 1, pp. 51-66
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top